Lexaria Bioscience Warrant
LEXXW
LEXXW was delisted on the 13th of January, 2026.
5 hedge funds and large institutions have $1.2M invested in Lexaria Bioscience Warrant in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
67% more funds holding
Funds holding: 3 → 5 (+2)
7% less capital invested
Capital invested by funds: $1.29M → $1.2M (-$84K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$148K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.53K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $613K | +$148K | +75,843 | +23% |
|
|
BFM
2
Boothbay Fund Management
New York
| $318K | – | – | – |
|
|
EAM
3
Empery Asset Management
New York
| $204K | +$261K | +133,333 | New |
|
|
CH
4
CVI Holdings
Wilmington,
Delaware
| $68K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $1K | +$1.53K | +784 | New |
|
LEXXW Hedge Fund Activity: Q4 2021 in Review
5 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Lexaria Bioscience Warrant (LEXXW) for Q4 2021, worth a combined $1.2M — down 6.5% from $1.29M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new LEXXW positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, adding an estimated $148K.
- 5 institutional investors held Lexaria Bioscience Warrant (LEXXW) as of Q4 2021, up from 3 in Q3 2021.
- Funds reported $1.2M of Lexaria Bioscience Warrant stock for Q4 2021, down 6.5% quarter-over-quarter.
- 2 funds opened new Lexaria Bioscience Warrant positions in Q4 2021 and 0 closed out, a net change of +2 holders.
- The largest Lexaria Bioscience Warrant buyer in Q4 2021 was Sabby Management, an estimated $148K added.
Based on aggregated 13F filings for Q4 2021.